Wes Wong

G2 Group

Wes Wong, Strategic Advisor

Wesley Blake Wong M.D., M.M.M., is an experienced physician executive with over 30 years of clinical practice and physician leadership. He has a demonstrated experience in clinical practice along with advancing roles and responsibilities in hospital and healthcare systems, medical management and the managed care industry. He recently served as Tandem Hospital Partners as VP, Medical Director and Managed Care in addition to serving as the CMO for the St. Vincent Neighborhood Hospitals in Indianapolis, IN.

Dr. Wong is a Board-Certified Neurologist with additional boards in Pain Management and Electrodiagnostic testing and Neuromuscular Diseases. He also completed a Masters in Medical Management. He received his medical degree at the University of Oklahoma Health Sciences Center and completed his Neurology residency at Indiana University. He went on to complete a fellowship in Neuromuscular Diseases at the Medical College of Georgia. Subsequently, he developed an interest in physician executive leadership and received a Master’s in Medical Management from Tulane University and the American College of Physician Executives. For more than twenty years he maintained an active clinical practice in Neurology, neuromuscular diseases and pain management.

Previously, Dr. Wong served as the Chief Integration Officer for Community Health Network, Indianapolis Indiana and while at Anthem Blue Cross and Blue Shield he served as Regional Vice President, National Accounts Central Region. While at St. Vincent Hospitals, Indianapolis, he served as the Executive Director for the Neuroscience Service Line. In addition, he served as Medical Director for the Medical Specialties Services Line, and Medical Director of the John S. Marten Pain Center and Complementary Medicine. He also served on the Ascension Clinical Excellence Team. Additional work with Ascension also included leading the Medication Safety Advisory Council (MSAC) for Ascension Health being responsible for developing definitions of medication error, establishing common reporting systems, detection of errors and achieving clinical measurements aimed at reducing medication errors and harm across 62 acute care hospitals.